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Summary
Vitamin D3 upregulated protein 1 (VDUP1) is a stress-
response gene that is upregulated by 1,25(OH)2D3 in
tumor cells. The in vivo roles of VDUP1 were investi-
gated by producing mice lacking VDUP1 (VDUP1−/−
mice). VDUP1−/− mice showed minimal changes in the
development of T and B cells, but there was a pro-
found reduction in the numbers of natural killer (NK)
cells. As well, these mice showed decreased NK ac-
tivity. In the VDUP1−/− mice, the expression of CD122
was reduced, demonstrating that VDUP1 is required
for CD122 expression and NK maturation. In addition,
severe lymphoid hyperplasia in the small intestine
was observed in VDUP1−/− mice. Taken together,
these results suggest that VDUP1 is a critical factor
for the development and function of NK cells in vivo.
Introduction
NK cells are large, granular lymphocytes that mediate
important functions in innate immunity and are capable
of eliminating major histocompatibility complex (MHC)*Correspondence: ipchoi@kribb.re.kr (I.C.); dyyu10@kribb.re.kr
(D.-Y.Y.)
6 These authors contributed equally to this work.class I-deficient virus-infected cells and tumor cells
(Colucci et al., 2002; Moretta et al., 2002).
NK cells are derived from hematopoietic stem cells
(HSCs) in the bone marrow (BM), which is the main site
of NK cell generation (Colucci et al., 2003; Raulet,
1999). The NK cell development from HSCs consists of
multiple steps, which are not yet completely defined,
and requires growth and differentiation signals from
stromal cells. In the embryo, HSCs give rise to NK pre-
cursors (pNKs), which are found in the fetal thymus,
blood, spleen, and liver. In the adult, pNKs are mainly
in the BM. pNKs are lineage negative and are charac-
terized by the presence of CD122 (IL-2 receptor β) and
the absence of both NK1.1 and DX5 NK markers (Lian
and Kumar, 2002). The murine pNKs are noncytolytic
and do not produce large amounts of IFN-γ. After in
vitro culture in the presence of IL-15 or IL-2, pNKs be-
come NKR-P1-positive, mature NK cells (mNK; NK1.1+
NK in mice and CD161+ NK in human). However, these
mature NK cells are negative for Ly49 receptors or KIR
repertoires. Fully functional Ly49+ mNK cells are gener-
ated when pNKs are incubated in the presence of OP9
stromal cells, indicating that the interaction between
the developing NK cells and stromal cells is important
for the proper maturation of NK cells (Iizuka et al., 1999;
Ogasawara et al., 1998).
In addition to growth factor signals, stage-specific
transcription factors are required for NK maturation.
ikaros-deficient mice showed low levels of FLT3 and
C-kit receptors, indicating that ikaros is required for
pNKs (Wang et al., 1996). Mice lacking PU.1, which reg-
ulates the expression of C-kit and IL-7 receptors, dem-
onstrated reduced numbers of pNKs (Colucci et al.,
2001). Overexpression of id2 in HSCs markedly en-
hanced NK development, whereas the generation of
other immune cells was blocked. In the same context,
the defection of id2 led to the selective inhibition of
pNK development (Ikawa et al., 2001).
Vitamin D3 upregulated protein 1 (VDUP1) was origi-
nally identified as a differentially expressed gene in
1α,25-dihydroxyvitamin D3 (1,25(OH)2D3)-treated HL-60
leukemia cells (Chen and DeLuca, 1994) and B16 mela-
noma cells (Song et al., 2003). VDUP1 interacts with an
antioxidant gene, thioredoxin (Trx), to inhibit the reduc-
ing activity of Trx and to block the interaction of Trx
with other factors, such as ASK-1 and PAG (Junn et
al., 2000a; Nishiyama et al., 1999). In addition, VDUP1
expression was also induced when the cell cycle was
blocked by growth-arrest stimuli (Junn et al., 2000a).
Meanwhile, VDUP1 expression is dominant in immune
cells, but its complete role in immune cells is not
known yet.
In this study, we have generated VDUP1-deficient
mice to investigate VDUP1’s in vivo functions. Com-
pared to wild-type (wt) mice, the population of some
immune cells was reduced in VDUP1−/− mice, espe-
cially NK cells. In VDUP1−/− mice, the numbers of
CD3−NK1.1+ cells and the NK cytotoxicity were re-
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awas also deceased in VDUP1-deficient mice.
t
wResults
a
(Generation of VDUP1-Deficient Mice
To knock out the VDUP1 by homologous recombina- c
(tion, the sequence from exon one to exon eight was
replaced by the lacZ and neo cassette genes (Figure A
w1A). Successful targeting of the VDUP1 gene was deter-
mined by Southern blot (Figure 1B) and polymerase
chain reaction (PCR) analysis (data not shown). Homo- D
izygous knockout mice were generated from the breed-
ing of VDUP1 heterozygous mice, and the complete TFigure 1. Targeted Mutation and Generation of VDUP1-Deficient Mice
(A) Genomic structure and targeting strategy. The wild-type allele with exons one to eight is shown above the targeting construct, and the
structure of the targeted allele is shown below. Bcl-1 restriction sites in the relevant region of the gene are indicated.
(B) Generation of homozygous mutant mice. Southern blot hybridization is shown with a 5# flanking probe to Bcl-1 digested genomic DNA
isolated from animals of an intercross with VDUP1+/− heterozygotes.
(C) Transmission of the targeted allele to the progeny as determined by RT-PCR.
(D) Northern blot analysis of different tissues from VDUP1−/− and VDUP1+/+ mice.
(E) Intracellular ROS level of lung fibroblasts was measured using DCFH-DA as described in Experimental Procedures.absence of VDUP1 RNA was confirmed by reverse-ranscriptase (RT)-PCR (Figure 1C) and Northern blot
nalysis (Figure 1D). Founder mice were backcrossed
o C57BL/6 mice for seven generations. VDUP1−/− mice
ere born healthy and developed normally throughout
dulthood. It is known that VDUP1 is an inhibitor of Trx
Junn et al., 2000a; Nishiyama et al., 1999). First, we
hecked the intracellular reactive oxygen species
ROS) level of lung fibroblast cells in VDUP1−/− mice.
s expected, ROS level was reduced in VDUP1−/− mice
hen compared to that of wt mice (Figure 1E).
evelopment of T and B Cells
n VDUP1-Deficient Mice
o characterize the phenotype of VDUP1−/− mice, a sin-gle-cell suspension was stained with various immune
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197cell markers and analyzed by flow cytometry. There
were no significant differences in thymic cellularity and
T cell populations in the VDUP1−/− mice compared to
littermate wt controls (Figure 2A). In the lymph nodes
(LN), no significant differences in the population of
CD4+ cells appeared between wt and VDUP1−/− mice.
CD8+ cell population was normal in thymus but some-
what (about 40% reduction) reduced in LN (Figure 2A)
and spleen (Table 1) from VDUP1−/− mice. The CTL ac-
tivity in spleen from VDUP1−/− mice was similarly re-
duced (33.2% reduction) compared to that from wt
mice (data not shown). In the BM and lung, the CD3+ T
cell and B220+ B cell population did not appear to be
changed dramatically (Figure 2B). The percentage of
CD4+CD25+ regulatory T cells was increased in the LN
(about a 2-fold increase), but not in the spleen of
VDUP1−/− mice (Figure 2C). No attempts were made to
demonstrate a possible increase in suppressive activ-
ity. When total cell numbers of immune cells in different
lymphoid organs were counted, there were no signifi-
cant differences in total T and B cell numbers between
wt and VDUP1−/− mice (Table 1). However, the numbers
of CD8+ cells were reduced (40% reduction in spleen
and LN).
It is known that VDUP1 is involved in cell-cycle pro-
gression by arresting the cell cycle at Go/G1. Recently,
it was reported that overexpression of VDUP1 in T cells
induced cell-cycle arrest in the G1 phase with an
increase of p16 expression (Nishinaka et al., 2004). In
addition, 1,25(OH)2D3 inhibited T cell activation and
proliferation independent of IL-2 receptor expression
and signaling (Rigby et al., 1985). Next, cell proliferation
was assayed in the presence of various T cell stimula-
tors. The proliferation of thymocytes and splenocytes
from VDUP1−/− mice was increased in the presence of
PMA plus ionomycin or anti-CD3 plus anti-CD28 (Figure
2D). Cell division of splenic T cells from VDUP1−/− mice
was increased as monitored by carboxylfluorescein di-
acetate succinimidyl ester (CFSE) labeling (see Figure
S1A in the Supplemental Data available with this article
online). Similarly, cell proliferation of T cells from
VDUP1−/− mice was also increased in the presence of
IL-2 (Figure S1B). In addition, Ig production from the
serum of VDUP1−/− mice was evaluated by isotype-spe-
cific ELISA. There were small differences in the IgG
subclass production in VDUP1−/− mice (Figure 2E),
whereas the amounts of IgA, IgM, and IgE were compa-
rable to those of the wt (data not shown). Overall, the
VDUP1 deficiency did not severely affect T and B cell
development, but it did induce cell proliferation, which
is related to cell cycle progression.
Impaired Development of NK Cells in VDUP1−/− Mice
VDUP1 was originally reported to be upregulated by
1,25(OH)2D3 (Chen and DeLuca, 1994), which regulates
NK cell activation (Balogh et al., 1999; Mariani et al.,
1999). Next, the development and functions of NK cells
were evaluated. The numbers of NK (CD3−NK1.1+) cells
were severely reduced in the spleen, BM, and lung of
VDUP1−/− C57BL6 mice (6%, 23%, and 5% of wt,
respectively) (Figure 3A and Table 1). The decreased
numbers of NKT (CD3+NK1.1+) cells also appeared in
the spleen, BM, and lung of the VDUP1−/− mice (16%,
25%, and 28% of wt, respectively). However, the per-centage of CD3+ T cells was not significantly affected
by the VDUP1 deficiency. In 129Sv mice, the numbers
of DX5+ NK cells in the BM and LN of the VDUP1−/−
mice were also greatly reduced compared to those of
wt mice (23% and 39% of wt, respectively) (Figure 3B).
In vitro Ly49 expression and NK maturation in the
developing NK cells is known to be dependent on mar-
row-derived stromal cells as well as IL-15, whereas
IL-15 alone leads to the generation of large numbers of
NK1.1+, but not the generation of Ly49− cells (Williams
et al., 1999). By comparing the expression of Ly49 re-
ceptors in splenocytes and BM cells, we determined
the state of NK cell maturation from these mice in vivo
(Figure 3C). The number of Ly49D+, Ly49G2+, Ly49C/F/
H/I+, and NKG2A/C/E+ cells in the NK1.1+ cell popula-
tion was markedly reduced in both the spleen (6%–40%
of wt) and the BM (0%–10% of wt) of VDUP1−/− mice.
Several studies have shown that multipotent HSCs dif-
ferentiate into mature cells in the BM of adult mice
(Douagi et al., 2002; Williams et al., 1999). The differ-
ences in the expression of Ly49 receptors between the
wt and VDUP1−/− mice were much higher in the BM
than those in the spleen. Moreover, NK activity in the
splenocytes of the VDUP1−/− mice was also reduced
when compared to the wt mice (Figure 3D). Also, IFN-γ
expression in the VDUP1−/− mice was lower than that
of the wt (data not shown). Collectively, these data from
the analyses of the cell phenotype and NK functions
suggest that NK cell development is severely defective
in VDUP1−/− mice.
Reduced CD122 Expression in VDUP1−/− Mice
For proper NK cell development, growth factors and
transcription factors are required. For example, growth
factors including stem cell factor (SCF), Fms-like tyro-
sine kinase 3 ligand (Flt3L), and IL-7 are required for the
differentiation of pNK from the HSCs. pNK cells express
receptors for IL-7, IL-15, and C-kit as well as transcrip-
tion factors such as PU.1, GATA3, id2, and ETS-1. When
normal HSCs were differentiated in the presence of
growth factors, VDUP1 was upregulated from the pNK
stage (Figure 4A). Next, to assess the capacity of in
vitro differentiation, HSCs obtained from VDUP1−/− and
wt mice were differentiated into NK cells in the same
manner and their CD122 expression, which is a key
marker for NK development, was compared. CD122
gene expression was reduced in the mNK cells of
VDUP1−/− mice (Figure 4B). The expression of other
genes related to NK cell differentiation, including PU.1,
ETS-1, LTβR, MEF, and id2 was not changed. After
differentiation from HSCs for 6 days in vitro, CD122+
NK1.1− or CD122+2B4+ population from HSCs of
VDUP1−/− mice was decreased compared to wt mice
(Figure 4C). The NK1.1+NKG2A+ mNK cell population
from HSCs of VDUP1−/− mice was also reduced after
further differentiation for another 6 days (Figure 4C).
The total cell numbers of pNK and mNK cells differenti-
ated from HSCs of VDUP1−/− and wt mice were summa-
rized in Table S1. Cell numbers of pNK and mNK dif-
ferentiated from HSCs of VDUP1−/− mice were reduced.
It is known that IL-15 is required for the survival of NK
cells (Carson et al., 1997). Similarly, IL-15 responsive-
ness of NK cells from VDUP1−/− mice was evaluated
(Figure S2). NK cells from VDUP1−/− mice were less re-
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198Figure 2. B and T Cell Development in VDUP1-Deficient Mice
(A) Phenotypes of CD4+ and CD8+ subsets from the thymus or lymph nodes (LN) were determined by two-color flow cytometric analysis
using indicated antibodies. The fluorescence intensity was analyzed from the gated lymphocyte population of wt (left) and VDUP1−/− (right)
mice. The numbers in each quadrant represent the percentages of cells.
(B) The percentage of CD3+ and B220+ cells was evaluated from the gated lymphocyte population of BM and lung. The results are representa-
tive of at least eight independent experiments with similar results.
(C) Phenotypes of CD4+ CD25+ cells from the spleen and lymph nodes.
(D) Thymocytes (left) or splenocytes (right) from wt and VDUP1−/− mice were incubated with either PMA (2 ng/ml) plus 0.2 g/ml of ionomycin
or with plate-bound CD3/CD28 antibodies (5 g/ml each) for 3 days. Cell proliferation was measure by [3H] thymidine uptake as described in
Experimental Procedures. Results are representative of three independent experiments and are expressed as the mean ± SD of triplicate
cultures. **p < 0.01 versus cpm of wt mice.
(E) The sera from wt (■) and VDUP1−/− (,) mice were collected at the age of 6-to-8 wks. Ig production was measured by ELISA from the
serum of individual mice (n = 6). Three independent experiments were performed with similar results, and the data represent the mean ± SD
of triplicate determinations from one representative experiment.
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Spleen Thymus Bone Marrow Lymph node Lung
+/+ −/− +/+ −/− +/+ −/− +/+ −/− +/+ −/−
Total cell 80 ± 1.2 81 ± 0.3 75 ± 2.1 76 ± 0.1 50 ± 1.4 52 ± 2.3 8.4 ± 3.0 8.2 ± 2.2 6.0 ± 1.2 6.0 ± 0.3
number
(×106)
T Cells 29 ± 0.1 29 ± 0.8 74.9 ± 2.7 75.6 ± 0.5 2.7 ± 0.9 1.9 ± 0.1* 6.7 ± 1.4 6.6 ± 3.1 2.3 ± 0.3 1.9 ± 0.6
(×106)
CD8 single 13 ± 2.6 8.7 ± 1.3 4.3 ± 1.8 3.8 ± 1.2 − − 3.2 ± 2.6 1.9 ± 2.1 − −
positive
B cells 39 ± 0.8 43 ± 1.5 − − 11.5 ± 0.5 10.9 ± 0.2 1.3 ± 1.0 1.4 ± 1.8 0.7 ± 1.7 1.1 ± 0.6
(×106)
NK cells 2.7 ± 2.3 0.2 ± 1.6* − − 2.2 ± 1.8 0.5 ± 0.1 0.8 ± 0.3 0.06 ± 0.6* 1.5 ± 1.2 0.07 ± 0.1*
(×106)
NKT cells 0.5 ± 1.4 0.08 ± 0.3 − − 0.6 ± 1.1 0.2 ± 0.8 0.04 ± 0.4 0.03 ± 0.8 0.04 ± 0.2 0.01 ± 0.6
(×106)
The numbers of immune cells were determined by calculating the absolute number of each cell type from the FACS profiles and by the total
number of cells. Results are expressed as mean ± SD of four separate experiments (n = 8). *p < 0.05 for +/+ versus −/− mice.sponsive to IL-15 compared to those from wt mice in
terms of differentiation and survival. Meanwhile, HSCs
were differentiated into NK cells in the presence of
1,25(OH)2D3. Treatment of IL-15 with 1,25(OH)2D3 in-
duced CD122 expression, and the populations of
CD122+NK1.1+ and NK1.1+ NKG2A+ were increased
when compared to IL-15 alone (Figure 4D). These data
indicate that VDUP1 affects CD122 expression and
early developmental stages of NK cells from HSCs.
However, CD122 expression of T cells from VDUP1−/−
mice was normal (Figure S1C), and the development
of dendritic cells from HSCs was not different between
VDUP1−/− and wt mice (Figure S3). These data suggest
that VDUP1 seems to have major roles in CD122 ex-
pression and NK cell development.
We next examined the in vivo population of CD122+
NK cells from VDUP1−/− mice. As expected, the per-
centages of CD122-expressing and/or NK1.1+ cells in
VDUP1−/− mice were markedly decreased (NK1.1+, 13%
and NK1.1+CD122+ cells, 7% in wt versus 3.6% and 0%
in VDUP1−/− mice) (Figure 4E), further confirming that
VDUP1 plays an essential role for NK cell development
via CD122 expression. To know the direct relation be-
tween VDUP1 and CD122 gene expression, the effects
of VDUP1 on CD122 promoter activity (Lin and Leonard,
1997) was assessed. VDUP1 induced CD122 promoter
activity in a dose-dependent manner (Figure 4F), indi-
cating that VDUP1 regulates CD122 gene expression
directly.
VDUP1−/− Mice Exhibit Hyperplasia and Reduced
Tumor Rejection
It is known that NK cell abnormality is related to many
diseases, including systemic lupus erythematosus
(Schattner and Duggan, 1984), intestinal hyperplasia
(Altmann et al., 1990), and tumors (Leu et al., 1985;
Mickel et al., 1988). In addition, several studies have
shown that CD122-deficient mice exhibited not only im-
paired NK cell development but also abnormal develop-
ment of intraepithelial lymphocytes (IELs) in the intes-
tine (Porter and Malek, 1999; Suzuki et al., 1997).
Therefore, we examined the histological changes of the
mucosal tissues of 4- to 6-month-old VDUP1−/− mice.A small lymph nodule was present in the ileum of wt
mice, but there was diffuse hyperplasia of lymphoid tis-
sue containing a large germinal center in the ileum of
VDUP1−/− mice (Figure 5A). In addition, immunohisto-
logical analysis of the NK cell population using a NK-
specific antibody showed that NK cells were reduced
in the lamina propria of the ileum in VDUP1−/− mice (Fig-
ure 5B). In addition, to investigate NK-mediated tumor
rejection in VDUP1−/− mice, an in vivo peritoneal tumor
clearance assay was performed. VDUP1−/− mice or wt
mice were injected intraperitoneally (i.p.) with CFSE-
labeled class I-deficient RMA-S cells, which are proto-
typic NK cell-sensitive targets for in vitro and in vivo
studies (Lee et al., 2004; Ljunggren and Karre, 1985).
After 3 days, the number of RMA-S cells in peritoneal-
lavage fluid of VDUP1−/− mice was 4-fold higher than
the number recovered in wt mice (Figure 5C). VDUP1−/−
mice rejected RMA-S tumor cells much less efficiently
than wt mice, indicating again that NK cells were de-
fective in VDUP1−/− mice.
IELs are mainly located between the epithelial cells
of the gut and play a central role in mucosal immune
responses (Fujihashi et al., 1990). To investigate which
types of immune cells were increased, we isolated IELs
and lamina propria lymphocytes (LPLs) from the small
intestine of VDUP1−/− mice. Total cell numbers of IELs
and LPLs in VDUP1−/− mice were increased 4- and 4.7-
fold, respectively, as compared to their wt littermates,
indicating that the increase in total cell numbers from
the gut of VDUP1−/− mice correlated with the intestinal
lymphocyte hyperplasia in immunohistochemical analy-
sis. It may be because lack of VDUP1 induces cell pro-
liferation in response to growth stimuli, as shown in T
cell proliferation. In IELs, VDUP1−/− mice were found by
flow cytometry to have a much lower percentage of
DX5+ NK cells than wt mice (3.4% in wt, 0.4% in
VDUP1−/− mice) (Figure 6A). Most activated B cells are
distributed in the gut, and LPLs is known to be both an
inductive and effector site for IgA responses (Brandt-
zaeg et al., 2001). The proportion of CD19+ and IgA-
expressing CD19+ B cells was increased in the LPLs
of VDUP1−/− mice compared with wt mice (Figure 6B).
However, the proportion of CD8αα+ cells in the LPLs of
Immunity
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(A) Single cell suspensions from the spleen, BM, and lung of wt and VDUP1−/− C57BL6 mice were stained with FITC-conjugated anti-CD3
and PE-conjugated anti-NK1.1 as described in Experimental Procedures. The percentage of the NK cells was evaluated from the gated
lymphocyte population.
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TCRαβ+TCRγδ+ and CD8αα+CD8β+ cells were analyzed
(Figure 6C). The proportion of TCRαβ+TCRγδ+ subsets
was not changed between VDUP1−/− and wt mice, but
the CD8αα+CD8β+ population was reduced in LPL from
VDUP1−/− mice. In addition, CD8+CD44hiCD122hi mem-
ory cells that were reduced in IL-15-deficient mice
(Judge et al., 2002) were evaluated. These phenotype
cells were not changed significantly in various tissues
of VDUP1−/− mice (Figure S4). Table S2 summarizes the
actual numbers of immune cell subsets in IEL and LPL.
Actual numbers of most subsets except NK cells were
elevated in VDUP1−/− mice, probably due to lympho-
cyte hyperplasia.
Discussion
In this study, we described the effects of VDUP1 on
in vivo NK development. In VDUP1-deficient mice, the
numbers and cytotoxicity of CD3−NK1.1+ NK cells were
reduced. Ly49 receptor expression was also reduced in
VDUP1−/− mice. CD122 expression was reduced during
the in vitro NK maturation of HSCs from VDUP1-defi-
cient mice compared to that of wt mice. The molecular
mechanisms of VDUP1 in NK development are not clear
yet, but several aspects can be speculated upon based
on the known functions of VDUP1. First, its roles in
CD122 expression are related to NK maturation.
VDUP1−/− mice showed reduced gene expression of
CD122, and VDUP1 transfection increased the pro-
moter activity of CD122 directly. Indeed, CD122 and its
ligands, IL-2 and IL-15, are essential factors for the
maturation of pNK cells (Colucci et al., 2003). It is also
known that CD122 gene expression is controlled by
several factors such as TGF-β1 and 1,25 (OH)2D3
(D’Angeac et al., 1991; Jordan et al., 1989), which are
well-known activators of VDUP1.
VDUP1 was previously reported as a transcriptional
repressor that suppressed the promoter activity of
cyclinA2 in association with other corepressors (Han et
al., 2003). However, it was reported that VDUP1 also
increased IL-6 gene expression in the presence of H2O2
(Junn et al., 2000a). Recently our results showed that
VDUP1 interacted with coactivators, including Jun acti-
vation domain binding protein 1, and induced gene ex-
pression of several signaling molecules (data not
shown), indicating that VDUP1 can either positively or
negatively regulate gene transcription in response to
stimulation. CD122 expression of T cells from VDUP1−/−
mice was normal, and IL-2 increased cell growth of T
cells from VDUP1−/− mice more compared to those from
wt mice. During development, CD122 expression is in-
duced in pNK, but not increased during early stages of
T cell development in the thymus (Anderson et al., significant differences in VDUP1 mice. IL-15-deficient
(B) To detect another surface marker expression for the NK cells, DX5 expression was analyzed from the BM and lymph nodes (LN) of wt and
VDUP1−/− 129Sv mice using FITC-conjugated anti-DX5 and PE-conjugated anti-CD3.
(C) The different Ly49 and NKG2 receptor expression was analyzed from the gated lymphocyte population of splenocytes and BM cells from
C57BL6 mice. The results are representative of at least eight independent experiments with similar results.
(D) Splenocytes from +/+ (C) and −/− (,) mice were cultured in the presence of IL-2 (10 U/ml) for 24 hr. After washing the cells, NK cell
cytotoxicity was determined by a 51Cr-release assay against YAC-1 target cells at the indicated E:T ratios. Data are expressed as a percentage
of the specific release and represent the mean ± SD of triplicate determinations.1999). In addition, CD122-deficient mice have normal
thymic T cells but reduced NK cells (Suzuki et al., 1997),
indicating that roles of CD122 in T cell development are
different from those in NK cell development. VDUP1 is
also induced at the pNK stage, when CD122 is in-
creased. The CD122 promoter is regulated by several
transcription factors such as sp1, EWS-WT1, and egr-1
(Wong et al., 2002), which are known to function as
transcriptional activators or repressors in response to
stimulation (Lin and Leonard, 1997; Wong et al., 2002).
However, little is known about the regulation of these
factors in NK and T cell development. Further studies
of these factors’ interactions with VDUP1 during devel-
opment are required to elucidate the difference of
CD122 expression in NK and T cells in VDUP1−/− mice.
Second, the roles of VDUP1 in redox regulation may be
related to NK cell development. In VDUP1−/− mice, the
intracellular ROS level was reduced as compared to wt
mice (Figure 1E). It is known that ROS and antioxidants
are involved in the activation and proliferation of im-
mune cells. NK cells are susceptible to the effects of
ROS, causing them to lose their activity (Nakamura and
Matsunaga, 1998) and contributing to NK cell dysfunc-
tion in leukemic granulocytes (Mellqvist et al., 2000).
Collectively, the dysregulation of intracellular ROS
levels could affect IL-2/IL-12 receptor expression and
NK differentiation. Third, the anti-proliferative functions
of VDUP1 may be involved in NK maturation. Cell cycle
progression and differentiation are physiologically
linked and controlled by the accessibility of mitogens
or differentiation signals (Casaccia-Bonnefil and Liu,
2003). Depending on these external signals and cell-
cycle components, cells will determine whether they
will continue to proliferate or differentiate. Therefore,
positive and negative regulators for cell cycle progression
control the balance of proliferation and differentiation.
1,25 (OH)2D3 is known to induce the differentiation of
CD34+ hematopoietic progenitors into monocytic-com-
mitted precursors and to increase the differentiation of
promyelocytic leukemia cells and myelomonocytic cells
(Verlinden et al., 1997). During NK cell development,
VDUP1 expression is induced from the pNKs. Upregu-
lated VDUP1 may induce cell-cycle arrest, which is nec-
essary for the onset of NK differentiation.
CD122-deficient and IL-15-deficient mice showed
the reduced NK population as shown in VDUP1−/− mice
in this study (Kennedy et al., 2000; Suzuki et al., 1997).
Meanwhile, CD122-deficient and IL-15-deficient mice
showed equivalent numbers of total IEL cells, but the
ratios of CD8αα+ and TCRγδ+ cells were reduced. In
VDUP1−/− mice, total IEL number was increased with
similar proportions of TCRγδ+ cells. In IL-15-deficient mice,
CD8+CD44hiCD122hi memory cells were decreased
about 60–80% (Judge et al., 2002), but there were no
−/−
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(A) NK cells were differentiated from HSCs of wt mice in vitro with growth factors as described in Experimental Procedures. Total cytoplasmic
RNA was isolated, and the expression of NK cell-associated genes was determined by RT-PCR at the different stages of NK differentiation.
One representative experiment of three is shown.
(B) NK cells were differentiated in vitro from HSCs of wt and VDUP1−/− mice. CD122 and other gene expression of wt and VDUP1−/− mice
were monitored by RT-PCR at the different stages of NK differentiation.
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(C) NK cells were differentiated in vitro from HSCs of wt and VDUP1−/− mice, and CD122 and other NK marker expression were analyzed by
flow cytometric analysis at the different stages of NK differentiation (CD122 at pNK; NKG2A at mNK). One representative experiment of three
is shown.
(D) NK cells were differentiated from HSCs of wt mice in vitro in the presence or absence of 10 nM 1,25(OH)2D3. After maturation (mNK),
CD122 or NKG2A expression was analyzed by flow cytometry or RT-PCR.
(E) CD122 expression in vivo in the small intestine from wt and VDUP1−/− mice was determined by flow cytometric analysis.
(F) 293T cells were transfected with 0.1 µg of CD122 promoter (−857/+97) luciferase reporter plasmid, 0.1 µg of renilla luciferase plasmid, and
the indicated amounts of VDUP1 cDNA. The total DNA concentration in each transfection was kept constant by adjusting with the empty
vector. After a 48 hr incubation, the cell lysates were assayed for luciferase activities according to the manufacturer’s instructions (Promega,
Madison, WI). Transfection efficiencies were normalized by measuring renilla luciferase activities. Data represent the mean ± SD of triplicate
determinations.mice also showed normal numbers of thymic CD8+
cells but reduced numbers of CD8αα+ cells in IEL (Ken-
nedy et al., 2000). In VDUP1−/− mice, thymic CD8+ cells
were normal, but lymph node and splenic CD8+ cells
were somewhat reduced, although reduction of CD8+
cells is much less than that of NK cells. In LPL, the
proportion of CD8αα+ cells was reduced, but the total
cell number was increased in VDUP1−/− mice. Recently,
it has been proposed that NK cells function in CTL gen-
eration and Th1 development (Geldhof et al., 2002;
Kelly et al., 2002). Depletion of NK cells prevented CTL
effector functions and reduced the population of CD8+
cells, but not CD4+ cells. The reduction of CD8+ cells
and CTL activity in VDUP1−/− mice may be partly due
to the reduction of NK cells. The direct or indirect roles
of VDUP1 in CD8+ cell development need to be investi-
gated further.
IEL cells—a unique subset of lymphocytes consisting
of extrathymic T lymphocytes, Thy-1+, and TCRαβ+ or
TCRγδ+—are located between the epithelial cells of the
gut mucosa and play a key role in mucosal immunity
(Hayday et al., 2001). Functionally, these IEL cells are
capable of natural killing. Meanwhile, LPL cells play an
important role in protection against infection through
the production of IgA. Intestinal LPL cells consist of
CD3+ T cells and CD19+ B cells (Brandtzaeg et al.,
1999). Abnormal development of IEL and NK cells was
observed in CD122-deficient mice (Suzuki et al., 1997).
In these mice, both populations of TCRαβ+CD8αα+ and
TCRγδ+ T cells were severely reduced. Based on the
regulatory effects of VDUP1 on CD122, we checked the
IEL and LPL populations in VDUP1−/− mice. The IEL and
LPL cells were severely affected by VDUP1 deficiency.
The increased total numbers of immune cell subsets in
IEL and LPL in VDUP1−/− mice may be related to regula-
tory roles of VDUP1 in cell proliferation and cell cycle
progression as reported previously (Han et al., 2003;
Nishinaka et al., 2004). Otherwise, as shown in CD122-
deficient mice, the ratios of CD8αα+ cell population
were reduced, but the ratios of B cells were increased
in LPL of VDUP1−/− mice.
Overall, VDUP1−/− mice showed significant reduction
of NK cells with somewhat reduced CD8+ cells and CTL
activity. In addition, the proportion of some immune
populations such as IEL and LPL in a specialized tissue
was changed. These results suggest that VDUP1 may
have a major role in the development of extrathymic
lymphocyte subsets as seen in CD122-deficient mice
(Suzuki et al., 1997). Based on the diverse functions of
NK cells in infection, diseases, and in interacting withthe other immune cells in VDUP1−/− mice in response
to immune stimuli remain to be defined.
Our previous reports showed that VDUP1 expression
was dramatically reduced in various lymphoid tissues
of patients with breast, lung, or stomach cancer (Han
et al., 2003), implying that VDUP1 is related to tumori-
genesis. VDUP1 deficiency seems to be related to NK
defection during NK development and reduced tumor
rejection in vivo, suggesting that regulation of VDUP1
expression can be a critical target for cancer therapy.
In conclusion, we produced VDUP1−/− mice that
showed significantly reduced populations of NK cells
and decreased cytotoxicity. In addition, the cell popula-
tions in the intestinal IEL and LPL cells were dysregu-
lated by the VDUP1 deficiency. VDUP1 might be an im-
portant regulator of immune cell differentiation by
regulating the CD122 expression and redox state dur-
ing this process.
Experimental Procedures
Generation of VDUP1−/− Mice
To produce VDUP1−/− mice by homologous recombination, a
targeting vector was constructed in which the sequence from exon
one to exon eight was replaced with the lacZ/neo cassette gene.
The vector was introduced into 129 Sv mouse embryonic stem (ES)
cells, and G418-resistant transformants containing the mutation in
one allele of the VDUP1 gene were selected. The ES clones were
injected into the blastocyst embryos of C57BL/6 mice to produce
chimeric mice, and the mutant allele was successfully transmitted
to the next generation via their germ line. The successful genera-
tion of VDUP1–/– mice was confirmed by PCR and Northern blot-
ting. The primers used were 5#-ATTCCCCTTCCAGGTGGA-3# and
5#-TTGAAATTGGCTCTGT-3# for the wild-type VDUP1 mice and
5#-GAAGCCAATATTGAAACCCA-3# and 5#-GCAAAGACCAGAC
CGTTCAT-3# for the lacZ gene. All animal procedures were con-
ducted in accordance with the guidelines of the Institutional Animal
Care and Use Committee, Korea Research Institute of Bioscience
and Biotechnology (KRIBB).
Antibodies and Flow Cytometric Analysis
All antibodies except NKG2A/C/E and Ly49C/F/H/I (Southern Bio-
technology Associates, Birmingham, AL) for flow cytometric analy-
sis were purchased from Becton Dickinson (BD) PharMingen (San
Diego, CA). Cells from individual tissues were stained with the indi-
cated antibodies in a staining buffer (PBS containing 1% FBS and
0.01% NaN3) for 10 min on ice and analyzed by two-color flow
cytometry on a FACScalibur by using CellQuest software (BD Bio-
sciences, Mountain View, CA).
In Vitro Differentiation of NK Cells from HSCs
NK differentiation from HSCs was essentially performed as de-
scribed previously (Williams et al., 1999). In brief, purified Lin−,
C-kit+ HSCs were plated into a 6-well plate (BD) at 2 × 106 cells/
well and cultured in complete RPMI medium supplemented with a
Immunity
204
An Essential Role of VDUP1 in NK Cell Development
205of [ H] thymidine (specific activity, 84.8 Ci/mmol; New England 37°C for 10 min, and the reaction was quenched with 5 volumes of
Figure 5. Intestinal Hyperplasia and Tumor Rejection in VDUP1−/− Mice
(A) Intestinal lymphoid hyperplasia in VDUP1−/− and wt mice. A small lymph nodule was present in the ileum of wt mice, but there was diffuse
hyperplasia of lymphoid tissue containing a large germinal center (*) in the ileum of VDUP1−/− mice (arrows, lymph nodule; hematoxilin-eosin
stain; original magnification, ×100).
(B) Immunohistological analysis of T and NK cells from wt and VDUP1−/− mice. J1j (T cell marker) and pk136 (NK cell marker) immunoreactive
cells were present in the lamina propria of the ileum of wt mice. The number of pk136 immunoreactive cells decreased significantly in the
ileum of VDUP1−/− mice (original magnification, 400×).
(C) In vivo tumor clearance assay in wt and VDUP1−/− mice. Wt and VDUP1−/− mice were injected i.p. with CFSE-labeled tumor cells. The
number of tumor cells recovered from the peritoneum after 3 days (depicted on y axis) was calculated on the basis of total number of
peritoneal exudates cells (indicated on x axis) multiplied by the percentage that were tumor cells as determined by the flow cytometry. Data
represent the mean ± SD of three independent experiments.Flt3L (50 ng/ml, PeproTech, Rocky Hill, NJ), mouse IL-7 (0.5 ng/ml,
PeproTech), indometacin (2 g/ml, Sigma), and gentamycin (20 g/ml)
for 6 days at 37°C, 5% CO2. Then, CD122+ pNK cells (>95% purity)
were positively selected by labeling the cells with FITC-conjugated
anti-CD122 and anti-FITC antibody coupled to MACS magnetic
beads. To generate the mNK cells, pNK cells were then cultured
with OP9 stromal cells (a gift from Dr. T. Nakano, University of
Osaka, Suita, Japan) in the presence of mouse IL-15 (20 ng/ml,
PeproTech). After 6 more days of culture, NK1.1+ cells were isolated
by using a FITC-conjugated anti-NK1.1 and anti-FITC antibody
coupled to the MACS magnetic beads. The purity of the mature NK
cells was determined by flow cytometric analysis by using anti-
CD122, NK1.1, DX5, and NK cell receptor antibodies.
Isolation of Small Intestinal IEL and LPL
IEL and LP lymphocytes were isolated from the small intestine as
previously described (Kang et al., 2002). In brief, the small intestine
was removed and all fat was dissected away from the intestine.
The intestine was longitudinally opened and extensively washed
with RPMI 1640 medium to exclude fecal materials. After cutting
the intestine into small pieces, the intestinal pieces were shaken in
20 ml of HBSS containing 2% FBS and 1 mM EDTA (Sigma Chemi-
cal, St. Louis, MO) for 30 min at room temperature. The cell suspen-
sions were then filtered on steel mesh and washed with RPMI 1640.
To purify the IEL from the cell suspensions, the cells were resus-
pended in 8 ml of 44% Percoll solution (Sigma) and then slowly
added to 5 ml of underlayered 67% Percoll. After centrifugation for
20 min at 2000 rpm, IEL were collected from the interface of the 44
and 55% Percoll solutions. To isolate the LPL from the cell suspen-
sions, the remaining intestinal pieces were incubated with RPMI
1640 containing 50 U/ml of collagenase (type VIII, Sigma) in a 37°C
shaking water bath for 15 min. After three additional incubations of
the pieces with the same collagenase, the supernatants were
washed twice and a 40/75% discontinuous Percoll gradient was
then performed. After harvesting the interface, the LPL were
washed twice and stained with antibodies as indicated for FACS
analysis.
NK Cytotoxicity Assay
Whole splenocytes were cultured in the presence of IL-2 (10 U/ml) for
24 hr. After washing, the cells were placed at the indicated effect-
or:target cell (E:T) ratios in a 96-well, round bottom microtiter tissue
culture plate. 51Cr-labeled YAC-1 target cells (1 × 104 cells per well)
were added to the wells in triplicate and incubated for 4 hr in a
37°C, 5% CO2-humidified incubator. After incubation, 100 µl of the
culture supernatant was collected, and radioactivity was detected
by γ-counting. Results are expressed as the percentage of the spe-
cific release based on the formula: percent specific release = (ex-
perimental release − spontaneous release) / (maximum release −
spontaneous release) × 100.
Cell Proliferation Assay
Isolated thymocytes and splenocytes (5 × 105/well) were plated on
96-well, flat-bottom microtiter plates (Costar) in 100 µl of RPMI
1640 supplemented with 20% FBS and 100 µl of PMA (2 ng/ml,
Sigma)/ionomycin (0.2 µg/ml, Sigma) or plate bound CD3/CD28 (5
µg/ml each, BD PharMingen) antibodies were added. For the [3H]
thymidine uptake assay, cells were incubated for 72 hr in a humidi-
fied 5% CO2 incubator at 37°C. The cells were pulsed with 0.5 µCi
3Nuclear, Boston, MA) for the last 6–16 hr of incubation and were
then harvested onto a glass-fiber filter using an automated cell har-
vester (Inotech, Zurich, Switzerland). The amount of radioactivity
incorporated into the DNA was determined by using a liquid scintil-
lation counter (LS 6000A; Beckman, Palo Alto, CA).
Immunohistochemistry
The ileum of the intestines of wt and VDUP1−/− mice were removed
and fixed in 10% neutral-buffered formalin overnight at 4°C. Frozen
sections of each tissue were prepared and collected in PBS in a
24 well plate. To perform the immunohistochemistry for J1j.10 and
pk136, the tissue sections were immersed for 30 min in 3% H2O2
to inactivate endogenous peroxidases. Sections were incubated in
the J1j.10 (1:500, ATCC, Manassas, VA) or pk136 antibody (1:500,
PharMingen) in 0.1 M PBS (pH 7.4) containing 0.1% Triton X-100
and 1.5% bovine serum albumin overnight at 4°C and 1:200 horse
serum for pk136 antibody or normal goat serum for J1j.10. Then,
the sections were incubated for 1 hr at room temperature in 1:200
fluorescein goat anti-rat whole serum (PharMingen) for J1j.10 anti-
body or fluorescein horse anti-mouse IgG (Vector) for pk136 anti-
body in 0.1 M PBS.
RT-PCR
To verify the different expressions of NK cell-associated genes from
the NK differentiation stage-specific cells, RT-PCR was performed
after quantitative normalization for each gene by densitometry
using β-actin gene expression. Briefly, the total cellular RNA was
extracted using RNAzol B (Tel-Test, Friendswood, TX) according to
the manufacturer’s instructions. Aliquots (3 g) of total RNA were
transcribed into cDNA at 37°C for 1 hr in a total volume of 20 l
with 2.5 U of Moloney murine leukemia virus reverse transcriptase
(Roche, Mannheim, Germany). Reverse-transcribed cDNA samples
were added to a PCR mixture consisting of 10× PCR buffer, 0.2 mM
dNTP, 0.5 U Taq DNA polymerase (Takara, Tokyo, Japan), and 10
pmol of primers for each gene. The primer sequences are as fol-
lows: mouse VDUP1, 5#-GCCGAATTCAAGATGGTGAAGCAGATC-
3# and 5#-GGCGGATCCTTAGACTAATTCATTAATGGTG-3#; perforin,
5#-GTCACGTCGAAGTACTTGGTG-3# and 5#-AACCAGCCACATA
GCACACAT-3#; granzyme B, 5#-GCCCACAACATCAAAGAACAG-3#
and 5#-AACCAGCCACATAGCACACAT-3#; CD122, 5#-GTCGAC
GCTCCTCTCAGCTGTGATGGCTACCATA-3# and 5#-GGATCCCAGA
AGACGTCTACGGGCCTCAAATTCCAA-3#; β-actin, 5#-GTGGGGCG
CCCCAGGCACCA-3# and 5#-CTCCTTAATGTCACGCACGATTTC-
3#. Amplifications were performed with 25 cycles for β-actin and at
30 cycles for the others. The amplification profile included denatur-
ation at 95°C for 1 min, primer annealing at 55°C for 1 min, and
extension at 72°C for 1 min, followed by an additional extension
step at 72°C for 10 min. PCR products were electrophoresed and
visualized by ethidium bromide staining.
Intracellular Staining of ROS
The intracellular ROS level was measured as described previously
(Junn et al., 2000b). Briefly, cells were loaded with 50 M 2#,7#-
dichlorofluorescein diacetate (DCFH-DA, Eastman Kodak, Roches-
ter, NY) for 5 min. The cells were then analyzed by flow cytometry
using a FACScalibur.
In Vivo Tumor Clearance Assay
RMA-S cells suspended in PBS were labeled with 10 uM CFSE at
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IELs (A) and LPLs (B) were isolated from the small intestine of wt and VDUP1−/− mice as described in Experimental Procedures. Two-color
flow cytometric analysis was performed using the indicated antibodies. Parentheses represent the total number of cells.
(C) TCRαβ+TCRγδ+ and CD8αα+CD8β+ expression was analyzed by flow cytometric analysis. Data are representative of three independent ex-
periments.culture media. Cells were washed in PBS, and 6 × 106 RMA-S cells S
Swere injected i.p. in 500 ul of PBS. After 3 days, the mice were
killed and the peritoneal cells were recovered. RMA-S tumor cells a
fwere distinguished by forward versus side scatter and CFSE la-
beling.
AStatistical Analysis
For the statistical analysis of the data, p values were analyzed
using a paired Student’s t test software program (Startview 5.1; W
aAbacus Concepts, Berkeley, CA). Results were considered statis-
tically significant when p values were <0.01. pupplemental Data
upplemental data including four figures and two tables are avail-
ble online with this article at http://www.immunity.com/cgi/content/
ull/22/2/195/DC1/.
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